Cargando…

Antiresorptive Agents are More Effective in Preventing Titanium Particle‐Induced Calvarial Osteolysis in Ovariectomized Mice Than Anabolic Agents in Short‐Term Administration

Aseptic loosening due to wear particle‐induced osteolysis is the main cause of arthroplasty failure and the influence of postmenopausal osteoporosis and anti‐osteoporosis treatment on Titanium (Ti) particle‐induced osteolysis remains unclear. 66 C57BL/6J female mice were used in this study. Ovariect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Guangtao, Li, Shixun, Ouyang, Nengtai, Wu, Junyan, Li, Changchuan, Liu, Wei, Qiu, Junxiong, Peng, Peng, Qin, Ling, Ding, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Electronic‐Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585759/ https://www.ncbi.nlm.nih.gov/pubmed/30328628 http://dx.doi.org/10.1111/aor.13271

Ejemplares similares

Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis: A meta-analysis
por: Lou, Shenghan, et al.
Publicado: (2017)

MiR-92a/KLF4/p110δ regulates titanium particles-induced macrophages inflammation and osteolysis
por: Wen, Zhenkang, et al.
Publicado: (2022)

HUCMSC‐derived Exosomes Suppress the Titanium Particles‐induced Osteolysis in Mice through Inhibiting CCL2 and CCL3
por: Li, Shixun, et al.
Publicado: (2023)

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”
por: Anastasilakis, Athanasios D, et al.
Publicado: (2022)

A Modified Murine Calvarial Osteolysis Model Exposed to Ti Particles in Aseptic Loosening
por: Deng, Zhantao, et al.
Publicado: (2020)

Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
por: Leder, Benjamin Z
Publicado: (2018)

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models
por: Paton‐Hough, Julia, et al.
Publicado: (2018)

Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs
por: del Real, Alvaro, et al.
Publicado: (2022)

Association between the ABO blood group and primary knee osteoarthritis: A case–control study
por: Li, Changchuan, et al.
Publicado: (2019)

Newly Shaped Intra‐Aortic Balloons Improve the Performance of Counterpulsation at the Semirecumbent Position: An In Vitro Study
por: Kolyva, Christina, et al.
Publicado: (2016)

Measurements of Intra‐Aortic Balloon Wall Movement During Inflation and Deflation: Effects of Angulation
por: Bruti, Gianpaolo, et al.
Publicado: (2015)

Visual Evoked Potential Recovery by Subretinal Implantation of Photoelectric Dye‐Coupled Thin Film Retinal Prosthesis in Monkey Eyes With Macular Degeneration
por: Matsuo, Toshihiko, et al.
Publicado: (2018)

Biocompatibility of Polysulfone Hemodialysis Membranes and Its Mechanisms: Involvement of Fibrinogen and Its Integrin Receptors in Activation of Platelets and Neutrophils
por: Koga, Yoko, et al.
Publicado: (2018)

A Computational Model of Heat Loss and Water Condensation on the Gas‐Side of Blood Oxygenators
por: Gómez Bardón, Ricardo, et al.
Publicado: (2018)

Continuous LVAD monitoring reveals high suction rates in clinically stable outpatients
por: Gross, Christoph, et al.
Publicado: (2020)

Ultrasound‐based estimation of remaining cardiac function in LVAD‐supported ex vivo hearts
por: Fixsen, Louis S., et al.
Publicado: (2020)

Dynamic measurement of centering forces on transvalvular cannulas
por: Stoiber, Martin, et al.
Publicado: (2019)

Efficient decellularization of equine tendon with preserved biomechanical properties and cytocompatibility for human tendon surgery indications
por: Aeberhard, Pierre‐Arnaud, et al.
Publicado: (2019)

Role of extracorporeal membrane oxygenation in critically Ill COVID‐19 patients and predictors of mortality
por: Zayat, Rashad, et al.
Publicado: (2020)

Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair: A review
por: Qayoom, I., et al.
Publicado: (2018)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo
por: Ottewell, PD, et al.
Publicado: (2006)

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016)

Disulfiram Attenuates Osteoclast Differentiation In Vitro: A Potential Antiresorptive Agent
por: Ying, Hua, et al.
Publicado: (2015)

Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OA
por: Bagi, Cedo M., et al.
Publicado: (2015)

Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes
por: Vilaca, Tatiane, et al.
Publicado: (2023)

The Use of Anabolic Agents in Catabolic States
por: Demling, Robert
Publicado: (2007)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017)

Effects of antiresorptive agents on body composition: a case-control retrospective study
por: Al Khayyat, Suhel Gabriele, et al.
Publicado: (2023)

Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021
por: Wadhwa, Harsh, et al.
Publicado: (2023)

Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women
por: Jordan, Natasha, et al.
Publicado: (2006)

Ecdysteroids: A novel class of anabolic agents?
por: Parr, MK, et al.
Publicado: (2015)

PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.
por: Saavedra, Minerva Montalvo, et al.
Publicado: (2023)

Curcumin Attenuation of Wear Particle-Induced Osteolysis via RANKL Signaling Pathway Suppression in Mouse Calvarial Model
por: Cheng, Tao, et al.
Publicado: (2017)

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
por: Anastasilakis, Athanasios D, et al.
Publicado: (2021)

Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan
por: Kunihara, Takahiro, et al.
Publicado: (2023)

Role of anabolic agents in colorectal carcinogenesis: Myths and realities
por: Krasanakis, Theodore, et al.
Publicado: (2019)

PB2646: THE COMPOSITE OF CHITOSAN WITH ASPARTIC ACID AS A PROMISING HEMOSTATIC AGENT
por: Obergan, Tamara, et al.
Publicado: (2023)

Scaling of titanium implants entrains inflammation-induced osteolysis
por: Eger, Michal, et al.
Publicado: (2017)

Mechanism and Prevention of Titanium Particle-Induced Inflammation and Osteolysis
por: Eger, Michal, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b5527rkldvkhidgj2oom02oek7